Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Valbiotis SA (ALVAL) Stock Price & Analysis

ALVAL Stock Chart & Stats

€0.63-€0.02(-3.24%)
At close: 5:30 PM GMT+1
EUR 0.5EUR 0.6EUR 0.7EUR 0.83 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 0.60 - EUR 0.66
52-Week Range
EUR 0.49 - EUR 1.27
Previous Close
EUR 0.65
Volume
46.37K
Average Volume (3M)
133.57K
Market Cap
EUR 22.31M
Enterprise Value
EUR 12.83M
Total Cash (Recent Filing)
EUR 8.68M
Total Debt (Recent Filing)
EUR 5.09M
Price to Earnings (P/E)
―
Beta
-0.15
Next Earnings
Mar 17, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Rebound

The reported 183.47% revenue growth indicates that revenue generation can rebound materially from a weak base. If this improvement persists, it could expand market traction and provide a larger platform for the company’s nutrition-health products over the next several quarters.

Manageable Leverage

Debt-to-equity of about 0.73 in 2025 suggests leverage remains manageable compared with a highly debt-dependent structure. This gives Valbiotis some balance-sheet capacity to continue developing and commercializing products, although losses still reduce financial flexibility.

Focused Nutrition-health Model

Valbiotis has a focused business model centered on nutrition-health solutions for cardiometabolic and metabolic conditions. Its use of research and clinical evaluation can support product credibility and differentiation as it builds a portfolio for prevention and health support.

Bears Say

Persistent Unprofitability

Persistent losses and deeply negative margins show that the current operating model is not yet economically self-sustaining. The very small revenue base relative to net loss leaves limited cost absorption, making a durable path to profitability dependent on substantial business improvement.

Ongoing Cash Burn

Repeated operating and free-cash-flow deficits mean Valbiotis is not funding operations internally. Continued burn increases dependence on external capital to sustain development and commercialization, potentially limiting strategic flexibility and raising the risk of future dilution.

Declining Balance-sheet Strength

Declining equity and assets indicate that accumulated losses are reducing the resources available to support the business. Persistently negative returns on equity also signal ongoing value erosion, which could constrain investment capacity and increase reliance on outside funding.

Valbiotis SA News

ALVAL FAQ

What was Valbiotis SA’s price range in the past 12 months?
Valbiotis SA lowest stock price was €0.49 and its highest was €1.27 in the past 12 months.
What is Valbiotis SA’s market cap?
Valbiotis SA’s market cap is €22.31M.
When is Valbiotis SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Valbiotis SA’s earnings last quarter?
Valbiotis SA released its earnings results on Oct 12, 2026. The company reported -€0.095 earnings per share for the quarter.
Is Valbiotis SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Valbiotis SA pay dividends?
Valbiotis SA does not currently pay dividends.
What is Valbiotis SA’s EPS estimate?
Valbiotis SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Valbiotis SA have?
Valbiotis SA has 35,538,235 shares outstanding.
What happened to Valbiotis SA’s price movement after its last earnings report?
Valbiotis SA reported an EPS of -€0.095 in its last earnings report. Following the earnings report the stock price went up 9.635%.
Which hedge fund is a major shareholder of Valbiotis SA?
Currently, no hedge funds are holding shares in FR:ALVAL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology